Imatinib as Pre-operative Anti-Colon Cancer Targeted Therapy

Clinical trial NCT02685046 · TERMINATED

Trial details

NCT number: NCT02685046
Sponsor: UMC Utrecht
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Colonic Neoplasms

Start date: 2016-04-01
Primary completion: 2019-09-01
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.